- 3.9Impact Factor
- 6.8CiteScore
- 18 daysTime to First Decision
Special Issues
Biomedicines publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Advances in Cardiac Remodeling
Deadline: 31 March 2026
Pancreatic Cancer: From Mechanisms to Therapeutic Approaches (4th Edition)
Deadline: 31 March 2026
Emerging Trends in Reproductive Endocrinology and Pregnancy-Related Disorders
Deadline: 31 March 2026
Applications of Biomedical Engineering and Biomaterials in Human Diseases
Deadline: 31 March 2026
Advances in Cancer Biology and Experimental Anticancer Therapies (3rd Edition)
Deadline: 31 March 2026
Recent Advances in Diagnosis, Therapeutics, and Mechanistic Research of Multiple Myeloma
Deadline: 31 March 2026
Emerging Technologies for In Vitro Models of Wound Healing
Deadline: 31 March 2026
Alpha-Synuclein in Neurodegeneration: From Pathophysiologic Mechanisms to Therapeutic Strategies
Deadline: 31 March 2026
Clinical and Translational Advances in Neuro-Ophthalmology
Deadline: 31 March 2026
Recent Advanced Research in Hypertension
Deadline: 31 March 2026
To Instill, to Deliver, to Implant, to Incise, to Protect: Innovations in Glaucoma Management—A Pharmaceutical Perspective
Deadline: 31 March 2026
Molecular Research in Genitourinary Oncology
Deadline: 31 March 2026
of 149

